참고문헌 (94)

1. J. Am. Coll. Cardiol. SM Grundy 47 1093 2006 10.1016/j.jacc.2005.11.046 Grundy, S. M. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J. Am. Coll. Cardiol. 47, 1093-1100 (2006). 

   상세보기

2. Am. J. Clin. Nutr. SM Grundy 83 1248 2006 10.1093/ajcn/83.6.1248 Grundy, S. M. Does a diagnosis of metabolic syndrome have value in clinical practice? Am. J. Clin. Nutr. 83, 1248-1251 (2006). 

   상세보기

3. Nature Rev. Drug Discov. SM Grundy 5 295 2006 10.1038/nrd2005 Grundy, S. M. Drug therapy of the metabolic syndrome: minimizing the emerging crisis of polypharmacy. Nature Rev. Drug Discov. 5, 295-309 (2006). 

   상세보기

4. Annu. Rev. Med. DE Moller 56 45 2005 10.1146/annurev.med.56.082103.104751 Moller, D. E. & Kaufman, K. D. Metabolic syndrome: a clinical and molecular perspective. Annu. Rev. Med. 56, 45-62 (2005). 

   상세보기

5. Curr. Opin. Lipidol. N Sattar 17 404 2006 10.1097/01.mol.0000236366.48593.07 Sattar, N. The metabolic syndrome: should current criteria influence clinical practice? Curr. Opin. Lipidol. 17, 404-411 (2006). 

   상세보기

6. Lancet RH Eckel 365 1415 2005 10.1016/S0140-6736(05)66378-7 Eckel, R. H., Grundy, S. M. & Zimmet, P. Z. The metabolic syndrome. Lancet 365, 1415-1428 (2005). 

   상세보기

7. Am. J. Clin. Nutr. GM Reaven 83 1237 2006 10.1093/ajcn/83.6.1237 Reaven, G. M. The metabolic syndrome: is this diagnosis necessary? Am. J. Clin. Nutr. 83, 1237-1247 (2006). 

   상세보기

8. Ann. Med. E Ferrannini 38 43 2006 10.1080/07853890500415358 Ferrannini, E. Is insulin resistance the cause of the metabolic syndrome? Ann. Med. 38, 43-51 (2006). 

   상세보기

9. Diabetologia EA Gale 48 1679 2005 10.1007/s00125-005-1873-5 Gale, E. A. The myth of the metabolic syndrome. Diabetologia 48, 1679-1683 (2005). 

   상세보기

10. Diabetes Care R Kahn 28 2289 2005 10.2337/diacare.28.9.2289 Kahn, R., Buse, J., Ferrannini, E. & Stern, M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28, 2289-2304 (2005). 

    상세보기

11. Clin. Chem. GM Reaven 51 931 2005 10.1373/clinchem.2005.048611 Reaven, G. M. The metabolic syndrome: requiescat in pace. Clin. Chem. 51, 931-938 (2005). 

    상세보기

12. Diabet. Med. KG Alberti 15 539 1998 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S Alberti, K. G. & Zimmet, P. Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 15, 539-553 (1998). 

    상세보기

13. 10.1001/jama.285.19.2486 Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). J. Am. Med. Assoc. 285, 2486-2497 (2001). 

    상세보기

14. Lancet KG Alberti 366 1059 2005 10.1016/S0140-6736(05)67402-8 Alberti, K. G., Zimmet, P. & Shaw, J. The metabolic syndrome - a new worldwide definition. Lancet 366, 1059-1062 (2005). 

    상세보기

15. Am. J. Med. A Galassi 119 812 2006 10.1016/j.amjmed.2006.02.031 Galassi, A., Reynolds, K. & He, J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am. J. Med. 119, 812-819 (2006). 

    상세보기

16. J. Am. Med. Assoc. AH Mokdad 289 76 2003 10.1001/jama.289.1.76 Mokdad, A. H. et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. J. Am. Med. Assoc. 289, 76-79 (2003). 

    상세보기

17. Nature P Zimmet 414 782 2001 10.1038/414782a Zimmet, P., Alberti, K. G. M. M. & Shaw, J. Global and societal implications of the diabetes epidemic. Nature 414, 782-787 (2001). 

    상세보기

18. Obesity Rev. A Astrup 1 57 2000 10.1046/j.1467-789x.2000.00013.x Astrup, A. & Finer, N. Redefining type 2 diabetes:'diabesity' or 'obesity dependent diabetes mellitus'? Obesity Rev. 1, 57-59 (2000). 

    상세보기

19. Diabetes Metab. E Shafrir 22 122 1996 Shafrir, E. Development and consequences of insulin resistance: lessons from animals with hyperinsulinaemia. Diabetes Metab. 22, 122-131 (1996). 

20. Lancet S Pincock 368 1643 2006 10.1016/S0140-6736(06)69682-7 Pincock, S. Paul Zimmet: fighting the 'diabesity' pandemic. Lancet 368, 1643 (2006). 

    상세보기

21. Arterioscler. Thromb. Vasc. Biol. JP Despres 20 1932 2000 10.1161/01.ATV.20.8.1932 Despres, J. P. et al. Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study. Arterioscler. Thromb. Vasc. Biol. 20, 1932-1938 (2000). 

    상세보기

22. Diabetes JB Albu 46 456 1997 10.2337/diab.46.3.456 Albu, J. B., Murphy, L., Frager, D. H., Johnson, J. A. & Pi-Sunyer, F. X. Visceral fat and race-dependent health risks in obese nondiabetic premenopausal women. Diabetes 46, 456-462 (1997). 

    상세보기

23. 10.1016/S0140-6736(03)15268-3 WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363, 157-163 (2004). 

    상세보기

24. Int. J. Obes. (Lond.) T Kadowaki 30 1163 2006 10.1038/sj.ijo.0803248 Kadowaki, T. et al. Japanese men have larger areas of visceral adipose tissue than Caucasian men in the same levels of waist circumference in a population-based study. Int. J. Obes. (Lond.) 30, 1163-1165 (2006). 

    상세보기

25. Metabolism JC Lovejoy 45 1119 1996 10.1016/S0026-0495(96)90011-6 Lovejoy, J. C., de la Bretonne, J. A., Klemperer, M. & Tulley, R. Abdominal fat distribution and metabolic risk factors: effects of race. Metabolism 45, 1119-1124 (1996). 

    상세보기

26. Am. J. Clin. Nutr. JM Conway 66 1345 1997 10.1093/ajcn/66.6.1345 Conway, J. M., Chanetsa, F. F. & Wang, P. Intrabdominal adipose tissue and anthropometric surrogates in African American women with upper- and lower-body obesity. Am. J. Clin. Nutr. 66, 1345-1351 (1997). 

    상세보기

27. J. Am. Coll. Cardiol. F Abbasi 40 937 2002 10.1016/S0735-1097(02)02051-X Abbasi, F., Brown, B. W., Lamendola, C., McLaughlin, T. & Reaven, G. M. Relationship between obesity, insulin resistance, and coronary heart disease risk. J. Am. Coll. Cardiol. 40, 937-943 (2002). 

    상세보기

28. Arteriosclerosis JP Despres 10 497 1990 10.1161/01.ATV.10.4.497 Despres, J. P. et al. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis 10, 497-511 (1990). 

    상세보기

29. Ann. Med. JP Despres 38 52 2006 10.1080/07853890500383895 Despres, J. P. Is visceral obesity the cause of the metabolic syndrome? Ann. Med. 38, 52-63 (2006). 

    상세보기

30. Diabetes Care P Bjorntorp 14 1132 1991 10.2337/diacare.14.12.1132 Bjorntorp, P. Metabolic implications of body fat distribution. Diabetes Care 14, 1132-1143 (1991). 

    상세보기

31. Physiol. Rev. AH Kissebah 74 761 1994 10.1152/physrev.1994.74.4.761 Kissebah, A. H. & Krakower, G. R. Regional adiposity and morbidity. Physiol. Rev. 74, 761-811 (1994). 

    상세보기

32. Diabetes Care HE Lebovitz 28 2322 2005 10.2337/diacare.28.9.2322 Lebovitz, H. E. & Banerji, M. A. Point: visceral adiposity is causally related to insulin resistance. Diabetes Care 28, 2322-2325 (2005). 

    상세보기

33. Diabetes SD Mittelman 51 755 2002 10.2337/diabetes.51.3.755 Mittelman, S. D., Van Citters, G. W., Kirkman, E. L. & Bergman, R. N. Extreme insulin resistance of the central adipose depot in vivo. Diabetes 51, 755-761 (2002). 

    상세보기

34. J. Lipid. Res. P Mauriege 36 672 1995 10.1016/S0022-2275(20)40053-7 Mauriege, P. et al. Regional variation in adipose tissue metabolism of severely obese premenopausal women. J. Lipid. Res. 36, 672-684 (1995). 

    상세보기

35. Obesity (Silver Spring) RN Bergman 14 Suppl. 1 16S 2006 10.1038/oby.2006.277 Bergman, R. N. et al. Why visceral fat is bad: mechanisms of the metabolic syndrome. Obesity (Silver Spring) 14 (Suppl. 1), 16S-19S (2006). 

    상세보기

36. Obesity (Silver Spring) MD Jensen 14 Suppl. 1 20S 2006 10.1038/oby.2006.278 Jensen, M. D. Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model. Obesity (Silver Spring) 14 (Suppl. 1), 20S-24S (2006). 

    상세보기

37. J. Clin. Invest. SP Weisberg 112 1796 2003 10.1172/JCI200319246 Weisberg, S. P. et al. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796-1808 (2003). 

    상세보기

38. Arterioscler. Thromb. Vasc. Biol. JS Yudkin 19 972 1999 10.1161/01.ATV.19.4.972 Yudkin, J. S., Stehouwer, C. D., Emeis, J. J. & Coppack, S. W. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler. Thromb. Vasc. Biol. 19, 972-978 (1999). 

    상세보기

39. J. Am. Coll. Cardiol. S Tsimikas 47 C19 2006 10.1016/j.jacc.2005.10.066 Tsimikas, S., Willerson, J. T. & Ridker, P. M. C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. J. Am. Coll. Cardiol. 47, C19-C31 (2006). 

    상세보기

40. Arterioscler. Thromb. Vasc. Biol. I Lemieux 21 961 2001 10.1161/01.ATV.21.6.961 Lemieux, I. et al. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler. Thromb. Vasc. Biol. 21, 961-967 (2001). 

    상세보기

41. Biochem. Biophys. Res. Commun. K Maeda 221 286 1996 10.1006/bbrc.1996.0587 Maeda, K. et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). Biochem. Biophys. Res. Commun. 221, 286-289 (1996). 

    상세보기

42. J. Biol. Chem. PE Scherer 270 26746 1995 10.1074/jbc.270.45.26746 Scherer, P. E., Williams, S., Fogliano, M., Baldini, G. & Lodish, H. F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 270, 26746-26749 (1995). 

    상세보기

43. J. Clin. Endocrinol. Metab. M Cote 90 1434 2005 10.1210/jc.2004-1711 Cote, M. et al. Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men. J. Clin. Endocrinol. Metab. 90, 1434-1439 (2005). 

    상세보기

44. Circ. Res. AH Berg 96 939 2005 10.1161/01.RES.0000163635.62927.34 Berg, A. H. & Scherer, P. E. Adipose tissue, inflammation, and cardiovascular disease. Circ. Res. 96, 939-949 (2005). 

    상세보기

45. Nature Clin. Pract. Cardiovasc. Med. Y Matsuzawa 3 35 2006 10.1038/ncpcardio0380 Matsuzawa, Y. Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nature Clin. Pract. Cardiovasc. Med. 3, 35-42 (2006). 

    상세보기

46. Obes. Res. I Lemieux 9 66S 2001 Lemieux, I. et al. Contribution of interleukin-6 and tumor necrosis factor-alpha to the elevated C-reactive protein levels found in abdominally obese men. Obes. Res. 9, 66S (2001). 

47. Int. J. Obes. Relat. Metab. Disord. GS Hotamisligil 24 Suppl. 4 S23 2000 10.1038/sj.ijo.0801497 Hotamisligil, G. S. Molecular mechanisms of insulin resistance and the role of the adipocyte. Int. J. Obes. Relat. Metab. Disord. 24 (Suppl. 4), S23-S27 (2000). 

    상세보기

48. Curr. Opin. Lipidol. PJ Havel 13 51 2002 10.1097/00041433-200202000-00008 Havel, P. J. Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin. Curr. Opin. Lipidol. 13, 51-59 (2002). 

    상세보기

49. Arterioscler. Thromb. Vasc. Biol. I Lemieux 24 795 2004 10.1161/01.ATV.0000126485.80373.33 Lemieux, I. Energy partitioning in gluteal-femoral fat: does the metabolic fate of triglycerides affect coronary heart disease risk? Arterioscler. Thromb. Vasc. Biol. 24, 795-797 (2004). 

    상세보기

50. Am. Heart J. PJ Miranda 149 33 2005 10.1016/j.ahj.2004.07.013 Miranda, P. J., DeFronzo, R. A., Califf, R. M. & Guyton, J. R. Metabolic syndrome: definition, pathophysiology, and mechanisms. Am. Heart J. 149, 33-45 (2005). 

    상세보기

51. J. Clin. Invest. O Gavrilova 105 271 2000 10.1172/JCI7901 Gavrilova, O. et al. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J. Clin. Invest. 105, 271-278 (2000). 

    상세보기

52. J. Biol. Chem. JK Kim 275 8456 2000 10.1074/jbc.275.12.8456 Kim, J. K., Gavrilova, O., Chen, Y., Reitman, M. L. & Shulman, G. I. Mechanism of insulin resistance in A-ZIP/F-1 fatless mice. J. Biol. Chem. 275, 8456-8460 (2000). 

    상세보기

53. Endocrinol. Metab. Clin. North Am. A Garg 33 305 2004 10.1016/j.ecl.2004.03.003 Garg, A. & Misra, A. Lipodystrophies: rare disorders causing metabolic syndrome. Endocrinol. Metab. Clin. North Am. 33, 305-331 (2004). 

    상세보기

54. Nature Genet. E Danforth 26 13 2000 10.1038/79111 Danforth, E. Failure of adipocyte differentiation causes type II diabetes mellitus? Nature Genet. 26, 13 (2000). 

    상세보기

55. J. Clin. Endocrinol. Metab. Y Miyazaki 87 2784 2002 10.1210/jcem.87.6.8567 Miyazaki, Y. et al. Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients. J. Clin. Endocrinol. Metab. 87, 2784-2791 (2002). 

    상세보기

56. Circulation PW Wilson 112 3066 2005 10.1161/CIRCULATIONAHA.105.539528 Wilson, P. W., D'Agostino, R. B., Parise, H., Sullivan, L. & Meigs, J. B. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112, 3066-3072 (2005). 

    상세보기

57. Am. J. Epidemiol. DE Laaksonen 156 1070 2002 10.1093/aje/kwf145 Laaksonen, D. E. et al. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am. J. Epidemiol. 156, 1070-1077 (2002). 

    상세보기

58. Ann. Intern. Med. MP Stern 136 575 2002 10.7326/0003-4819-136-8-200204160-00006 Stern, M. P., Williams, K. & Haffner, S. M. Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann. Intern. Med. 136, 575-581 (2002). 

    상세보기

59. Diabetes Care BE Klein 25 1790 2002 10.2337/diacare.25.10.1790 Klein, B. E., Klein, R. & Lee, K. E. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in beaver dam. Diabetes Care 25, 1790-1794 (2002). 

    상세보기

60. Am. Heart J. A Macchia 151 754.e7 2006 10.1016/j.ahj.2005.10.023 Macchia, A. et al. A clinically practicable diagnostic score for metabolic syndrome improves its predictivity of diabetes mellitus: the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI)-Prevenzione scoring. Am. Heart J. 151, 754.e7-754.e17 (2006). 

    상세보기

61. 10.1016/S0140-6736(98)07037-8 UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352, 854-865 (1998). 

    상세보기

62. Circulation P Libby 106 2760 2002 10.1161/01.CIR.0000037282.92395.AE Libby, P. & Plutzky, J. Diabetic macrovascular disease: the glucose paradox? Circulation 106, 2760-2763 (2002). 

    상세보기

63. Diabetes M Laakso 48 937 1999 10.2337/diabetes.48.5.937 Laakso, M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 48, 937-942 (1999). 

    상세보기

64. Circulation SM Grundy 109 433 2004 10.1161/01.CIR.0000111245.75752.C6 Grundy, S. M. et al. Definition of metabolic syndrome. Report of the National Heart, Lung and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109, 433-438 (2004). 

    상세보기

65. Diabetes SH Golden 51 3069 2002 10.2337/diabetes.51.10.3069 Golden, S. H. et al. Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis: the atherosclerosis risk in communities study. Diabetes 51, 3069-3076 (2002). 

    상세보기

66. Circulation PW Wilson 97 1837 1998 10.1161/01.CIR.97.18.1837 Wilson, P. W. et al. Prediction of coronary heart disease using risk factor categories. Circulation 97, 1837-1847 (1998). 

    상세보기

67. Arch. Intern. Med. SG Wannamethee 165 2644 2005 10.1001/archinte.165.22.2644 Wannamethee, S. G., Shaper, A. G., Lennon, L. & Morris, R. W. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch. Intern. Med. 165, 2644-2650 (2005). 

    상세보기

68. Diabetes Care MP Stern 27 2676 2004 10.2337/diacare.27.11.2676 Stern, M. P., Williams, K., Gonzalez-Villalpando, C., Hunt, K. J. & Haffner, S. M. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care 27, 2676-2681 (2004). 

    상세보기

69. Circulation G Assmann 105 310 2002 10.1161/hc0302.102575 Assmann, G., Cullen, P. & Schulte, H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation 105, 310-315 (2002). 

    상세보기

70. Am. J. Cardiol. CJ Girman 93 136 2004 10.1016/j.amjcard.2003.09.028 Girman, C. J. et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am. J. Cardiol. 93, 136-141 (2004). 

    상세보기

71. J. Am. Med. Assoc. B Lamarche 279 1955 1998 10.1001/jama.279.24.1955 Lamarche, B. et al. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. J. Am. Med. Assoc. 279, 1955-1961 (1998). 

    상세보기

72. Curr. Atheroscler. Rep. RA Hegele 2 397 2000 10.1007/s11883-000-0078-0 Hegele, R. A. Insulin resistance in human partial lipodystrophy. Curr. Atheroscler. Rep. 2, 397-404 (2000). 

    상세보기

73. Ann. Intern. Med. E Barrett-Connor 111 783 1989 10.7326/0003-4819-111-10-783 Barrett-Connor, E. & Khaw, K. T. Cigarette smoking and increased central adiposity. Ann. Intern. Med. 111, 783-787 (1989). 

    상세보기

74. J. Am. Med. Assoc. H Shimokata 261 1169 1989 10.1001/jama.1989.03420080089037 Shimokata, H., Muller, D. C. & Andres, R. Studies in the distribution of body fat. III. Effects of cigarette smoking. J. Am. Med. Assoc. 261, 1169-1173 (1989). 

    상세보기

75. J. Am. Coll. Cardiol. G Reaven 41 1044 2003 10.1016/S0735-1097(02)02982-0 Reaven, G. & Tsao, P. S. Insulin resistance and compensatory hyperinsulinemia: the key player between cigarette smoking and cardiovascular disease? J. Am. Coll. Cardiol. 41, 1044-1047 (2003). 

    상세보기

76. Diabetes MC Pouliot 41 826 1992 10.2337/diab.41.7.826 Pouliot, M. C. et al. Visceral obesity in men. Associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes 41, 826-834 (1992). 

    상세보기

77. Brit. Med. J. JP Despres 322 716 2001 10.1136/bmj.322.7288.716 Despres, J. P., Lemieux, I. & Prud'homme, D. Treatment of obesity: need to focus on high risk abdominally obese patients. Brit. Med. J. 322, 716-720 (2001). 

    상세보기

78. Int. J. Obes. Relat. Metab. Disord. ME Jorgensen 27 1507 2003 10.1038/sj.ijo.0802434 Jorgensen, M. E. et al. Obesity and central fat pattern among Greenland Inuit and a general population of Denmark (Inter99): relationship to metabolic risk factors. Int. J. Obes. Relat. Metab. Disord. 27, 1507-1515 (2003). 

    상세보기

79. Ann. Intern. Med. R Ross 133 92 2000 10.7326/0003-4819-133-2-200007180-00008 Ross, R. et al. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann. Intern. Med. 133, 92-103 (2000). 

    상세보기

80. Ann. Intern. Med. TJ Orchard 142 611 2005 10.7326/0003-4819-142-8-200504190-00009 Orchard, T. J. et al. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann. Intern. Med. 142, 611-619 (2005). 

    상세보기

81. Med. Sci. Sports Exerc. PT Katzmarzyk 35 1703 2003 10.1249/01.MSS.0000089337.73244.9B Katzmarzyk, P. T. et al. Targeting the metabolic syndrome with exercise: evidence from the HERITAGE Family Study. Med. Sci. Sports Exerc. 35, 1703-1709 (2003). 

    상세보기

82. Int. J. Obes. Relat. Metab. Disord. M Dumont 25 1136 2001 10.1038/sj.ijo.0801665 Dumont, M., Mauriege, P., Bergeron, J., Despres, J. P. & Prud'homme, D. Effect of a six month gemfibrozil treatment and dietary recommendations on the metabolic risk profile of visceral obese men. Int. J. Obes. Relat. Metab. Disord. 25, 1136-1143 (2001). 

    상세보기

83. Med. Sci. Sports Exerc. AS Leon 33 S502 2001 10.1097/00005768-200106001-00021 Leon, A. S. & Sanchez, O. A. Response of blood lipids to exercise training alone or combined with dietary intervention. Med. Sci. Sports Exerc. 33, S502-S515 (2001). 

    상세보기

84. Diabetes Care I Lemieux 29 1417 2006 10.2337/dc06-0441 Lemieux, I. et al. Waist girth does not predict metabolic complications in severely obese men. Diabetes Care 29, 1417-1419 (2006). 

    상세보기

85. Circulation I Lemieux 102 179 2000 10.1161/01.CIR.102.2.179 Lemieux, I. et al. Hypertriglyceridemic waist. A marker of the atherogenic metabolic triad (hyperinsulinemia, hyperapolipoprotein B, small, dense LDL) in men? Circulation 102, 179-184 (2000). 

    상세보기

86. Curr. Opin. Lipidol. PM Underwood 15 495 2004 10.1097/01.mol.0000137237.97341.fd Underwood, P. M. Cardiovascular risk, the metabolic syndrome and the hypertriglyceridaemic waist. Curr. Opin. Lipidol. 15, 495-497 (2004). 

    상세보기

87. Am. J. Clin. Nutr. HS Kahn 78 928 2003 10.1093/ajcn/78.5.928 Kahn, H. S. & Valdez, R. Metabolic risks identified by the combination of enlarged waist and elevated triacylglycerol concentration. Am. J. Clin. Nutr. 78, 928-934 (2003). 

    상세보기

88. Br. Med. J. ME Lean 311 158 1995 10.1136/bmj.311.6998.158 Lean, M. E., Han, T. S. & Morrison, C. E. Waist circumference as a measure for indicating need for weight management. Br. Med. J. 311, 158-161 (1995). 

    상세보기

89. Am. J. Clin. Nutr. S Zhu 76 743 2002 10.1093/ajcn/76.4.743 Zhu, S. et al. Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds. Am. J. Clin. Nutr. 76, 743-749 (2002). 

    상세보기

90. DOC News ET Beckley 3 1 2006 Beckley, E. T. New ADA initiative moves beyond 'metabolic syndrome'. 'Cardiometabolic risk' proposed as umbrella term for diabetes risk factors. DOC News 3, 1-3 (2006). 

91. Circulation RH Eckel 113 2943 2006 10.1161/CIRCULATIONAHA.106.176583 Eckel, R. H., Kahn, R., Robertson, R. M. & Rizza, R. A. Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. Circulation 113, 2943-2946 (2006). 

    상세보기

92. Despres, J. P. From CVD risk to cardiometabolic risk. Presented at the Symposium of the International Chair on Cardiometabolic Risk. XIV International Symposium on Atherosclerosis (Rome, 18-22 June 2006). 

93. Despres, J. P. Visceral adiposity. Presented at the 66th Scientific Sessions, American Diabetes Association (Washington, DC, 9-13 June 2006). 

94. N. Engl. J. Med. C Bouchard 322 1477 1990 10.1056/NEJM199005243222101 Bouchard, C. et al. The response to long-term overfeeding in identical twins. N. Engl. J. Med. 322, 1477-1482 (1990). 

    상세보기